Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...
The daily pill may provide a more convenient alternative to injections, which patients can find difficult to administer.
Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...
Weight loss surgery and medications have both been successful in helping patients shed weight, but surgery has been found to ...
The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...
Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways ...
The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...
While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...
The GoodRx for Weight Loss telemedicine subscription is available for an introductory rate of $39 per month through January ...
Remedy Meds is an online consumer health and pharmacy platform that provides access to compounded glucagon-like peptide-one ...
A new generation of companies is eyeing the existing, sizeable hair loss market, hoping that better formulations and new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results